Old Web
English
Sign In
Acemap
>
authorDetail
>
Federico Donfrancesco
Federico Donfrancesco
Pasireotide
Acromegaly
Medicine
Oncology
Internal medicine
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: Clinical effectiveness and predictors of response.
2020
European Journal of Endocrinology
Sabrina Chiloiro
Antonella Giampietro
Federica Mirra
Federico Donfrancesco
Tommaso Tartaglione
Pier Paolo Mattogno
Flavia Angelini
Liverana Lauretti
Marco Gessi
Carmelo Anile
Guido Rindi
Andrea Giustina
Maria Fleseriu
Alfredo Pontecorvi
Laura De Marinis
Antonio Bianchi
Show All
Source
Cite
Save
Citations (5)
Predictors of response to medical therapy with pegvisomant and pasireotide lar in SRLs-resistant acromegaly
2020
Sabrina Chiloiro
Antonella Giampietro
Antonio Bianchi
Federica Mirra
Federico Donfrancesco
Fleseriu Cara Maya
Liveraba Lauretti
C. Anile
Marco Gessi
G. Rindi
Alfredo Pontecorvi
Maria Fleseriu
Andrea Giustina
Marinis Laura De
Show All
Source
Cite
Save
Citations (0)
Effects of pegvisomant and pasireotide LAR on incidence of vertebral fractures in patients with acromegaly resistant to treatment with first-line somatostatin analogs
2019
Sabrina Chiloiro
Antonella Giampietro
Antonio Bianchi
Chiara Bima
Stefano Frara
Federica Mirra
Federico Donfrancesco
Cara Maria Fleseriu
Maria Fleseriu
Andrea Giustina
De Marinis Laura
Alfredo Pontecorvi
Show All
Source
Cite
Save
Citations (0)
Efficacy of pasireotide lar in first line somatostatin analogue resistant acromegaly patients: experience from a large and single centre Italian cohort
2018
Sabrina Chiloiro
Antonella Giampietro
Antonio Bianchi
Tommaso Tartaglione
Chiara Bima
Serena Piacentini
Federica Mirra
Federico Donfrancesco
Liverana Lauretti
Carmelo Anile
Alfredo Pontecorvi
Marinis Laura De
Show All
Source
Cite
Save
Citations (0)
1